03.10.15
Phillips-Medisize Corp. has appointed John Sills as chief financial officer (CFO), effective March 15. Sills succeeds E. Gary Willenbrecht, who is retiring.
According to Phillips-Medisize officials, Sills is working closely with Willenbrecht to ensure a smooth transition.
“John brings deep knowledge of the healthcare market as well as transaction-related and public offering expertise. We believe he will be a great asset to Phillips-Medisize as we continue to execute on our strategic plan to drive the next phase of our growth. We are pleased to have John join our team and look forward to what lies ahead,” said Matt Jennings, chairman and CEO of Phillips-Medisize.
Jennings thanked Willenbrecht for his service to the company.
“His leadership, financial acumen and insights have helped position Phillips-Medisize well for growth in the rapidly expanding medical outsourcing market,” Jennings added.
For the past eight years, Sills was the chief financial officer and chief administrative officer (CAO) of Unisource Worldwide Inc., a $4.2 billion international paper, packaging and facilities supply distribution company. He recently helped lead Unisource’s successful merger and subsequent public offering with Xpedx International, a division of International Paper, to form Veritive Corp, a $10 billion publicly traded company.
Prior to Unisource, Sills was the president and CEO of Medical Specialties Group, a supplier of healthcare products and biomedical equipment to the home healthcare industry. Before that, Sills was the CFO and CAO for Roberson-Ceco Corp, a contract engineering, design and manufacturer for the global commercial building industry.
Sills has an undergraduate degree from Lehigh University in accounting and finance, and an MBA from Northeastern University. He also is a certified public accountant.
Phillips-Medisize provides outsource design, product development and manufacturing services, with experience in advanced molding and assembly, primarily in the medical device and diagnostics, drug delivery, and pharmaceutical packaging markets. A total of 80 percent of the company’s total revenue comes from drug delivery, medical device and diagnostic products, such as disposable insulin pens, glucose meters, specialty inhalation drug delivery devices, single-use surgical devices and consumable diagnostic components.
The company is based in Hudson, Wis., and employs more than 3,400 people in 14 locations throughout the United States, Europe, Mexico and China. The company also has design centers in Wisconsin, California, and the Netherlands.
According to Phillips-Medisize officials, Sills is working closely with Willenbrecht to ensure a smooth transition.
“John brings deep knowledge of the healthcare market as well as transaction-related and public offering expertise. We believe he will be a great asset to Phillips-Medisize as we continue to execute on our strategic plan to drive the next phase of our growth. We are pleased to have John join our team and look forward to what lies ahead,” said Matt Jennings, chairman and CEO of Phillips-Medisize.
Jennings thanked Willenbrecht for his service to the company.
“His leadership, financial acumen and insights have helped position Phillips-Medisize well for growth in the rapidly expanding medical outsourcing market,” Jennings added.
For the past eight years, Sills was the chief financial officer and chief administrative officer (CAO) of Unisource Worldwide Inc., a $4.2 billion international paper, packaging and facilities supply distribution company. He recently helped lead Unisource’s successful merger and subsequent public offering with Xpedx International, a division of International Paper, to form Veritive Corp, a $10 billion publicly traded company.
Prior to Unisource, Sills was the president and CEO of Medical Specialties Group, a supplier of healthcare products and biomedical equipment to the home healthcare industry. Before that, Sills was the CFO and CAO for Roberson-Ceco Corp, a contract engineering, design and manufacturer for the global commercial building industry.
Sills has an undergraduate degree from Lehigh University in accounting and finance, and an MBA from Northeastern University. He also is a certified public accountant.
Phillips-Medisize provides outsource design, product development and manufacturing services, with experience in advanced molding and assembly, primarily in the medical device and diagnostics, drug delivery, and pharmaceutical packaging markets. A total of 80 percent of the company’s total revenue comes from drug delivery, medical device and diagnostic products, such as disposable insulin pens, glucose meters, specialty inhalation drug delivery devices, single-use surgical devices and consumable diagnostic components.
The company is based in Hudson, Wis., and employs more than 3,400 people in 14 locations throughout the United States, Europe, Mexico and China. The company also has design centers in Wisconsin, California, and the Netherlands.